TLDR Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.
The document describes a case where a 39-year-old male with non-segmental vitiligo achieved significant repigmentation after combining platelet-rich plasma (PRP) injections with narrow-band ultraviolet B (NB-UVB) phototherapy. Initially, after 17 sessions of NB-UVB alone, there was minimal improvement, but with the addition of PRP, over 50% improvement was observed in two months, and over 75% after a six-week break. This case suggests that PRP may boost the effectiveness of phototherapy in treating vitiligo and is a safe treatment option, though the authors recommend further large-scale studies to confirm these findings.
26 citations,
June 2019 in “The journal of investigative dermatology/Journal of investigative dermatology” Regenerative therapies show promise for treating vitiligo and alopecia areata.
15 citations,
March 2018 in “Journal of The American Academy of Dermatology” PRP therapy improves hair density and thickness in AGA patients, even with other treatments.
79 citations,
March 2017 in “Dermatologic clinics” Vitiligo affects overall health and self-esteem, needing more research and awareness.
3 citations,
August 2020 in “PubMed” Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.
1 citations,
November 2022 in “Journal of Dermatological Treatment” Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.
July 2024 in “Periodontology 2000” Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.
May 2024 in “Pigment International” Several treatments are effective for pigmentary disorders like vitiligo and melasma.
26 citations,
June 2019 in “The journal of investigative dermatology/Journal of investigative dermatology” Regenerative therapies show promise for treating vitiligo and alopecia areata.